Symbol:
TNFSF4
Name:
TNF superfamily member 4
RGD ID:
1345164
HGNC Page
HGNC:11934
Description:
Predicted to enable tumor necrosis factor receptor superfamily binding activity. Involved in several processes, including cellular response to lipopolysaccharide; cellular response to prostaglandin E stimulus; and regulation of cytokine production. Located in cell surface and extracellular space. Implicated in myocardial infarction. Biomarker of cervical squamous cell carcinoma.
Type:
protein-coding
RefSeq Status:
REVIEWED
Previously known as:
CD134 ligand; CD134L; CD252; glycoprotein Gp34; GP34; OX-40L; OX40 antigen ligand; OX40L; OX4OL; TAX transcriptionally-activated glycoprotein 1; tax-transcriptionally activated glycoprotein 1 (34kD); TNLG2B; tumor necrosis factor (ligand) superfamily member 4; tumor necrosis factor ligand 2B; tumor necrosis factor ligand superfamily member 4; tumor necrosis factor superfamily member 4; TXGP1
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Tnfsf4 (tumor necrosis factor (ligand) superfamily, member 4)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Tnfsf4 (TNF superfamily member 4)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Tnfsf4 (TNF superfamily member 4)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
TNFSF4 (TNF superfamily member 4)
NCBI
Ortholog
Canis lupus familiaris (dog):
TNFSF4 (TNF superfamily member 4)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Tnfsf4 (TNF superfamily member 4)
NCBI
Ortholog
Sus scrofa (pig):
TNFSF4 (TNF superfamily member 4)
HGNC
EggNOG, Ensembl, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):
TNFSF4 (TNF superfamily member 4)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Tnfsf4 (TNF superfamily member 4)
NCBI
Ortholog
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Tnfsf4 (TNF superfamily member 4)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Tnfsf4 (tumor necrosis factor (ligand) superfamily, member 4)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 173,172,870 - 173,450,733 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 173,162,645 - 173,477,583 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 173,152,870 - 173,176,470 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 171,419,493 - 171,443,094 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 169,884,527 - 169,908,128 NCBI Celera 1 146,262,332 - 146,285,933 (-) NCBI Celera Cytogenetic Map 1 q25.1 NCBI HuRef 1 144,377,608 - 144,401,209 (-) NCBI HuRef CHM1_1 1 174,575,344 - 174,598,945 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 172,541,831 - 172,768,144 (-) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
TNFSF4 Human (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of TNFSF4 mRNA CTD PMID:23649840 TNFSF4 Human 1D-myo-inositol 1,4,5-trisphosphate increases abundance EXP 6480464 TNFSF4 protein results in increased abundance of Inositol 1 more ... CTD PMID:19416722 TNFSF4 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Tnfsf4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of TNFSF4 mRNA CTD PMID:18684927 TNFSF4 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of TNFSF4 mRNA CTD PMID:32109520 TNFSF4 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TNFSF4 mRNA CTD PMID:20106945 and PMID:21632981 TNFSF4 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Tnfsf4 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of TNFSF4 mRNA CTD PMID:14718646 and PMID:15972635 TNFSF4 Human 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of TNFSF4 mRNA CTD PMID:23537331 TNFSF4 Human 2-palmitoylglycerol increases expression EXP 6480464 2-palmitoylglycerol results in increased expression of TNFSF4 mRNA CTD PMID:37199045 TNFSF4 Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFSF4 mRNA CTD PMID:16997883 TNFSF4 Human 6-propyl-2-thiouracil increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of TNFSF4 mRNA CTD PMID:24780913 TNFSF4 Human 8-Br-cAMP multiple interactions EXP 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFSF4 mRNA CTD PMID:16997883 TNFSF4 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of TNFSF4 protein CTD PMID:20106945 TNFSF4 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TNFSF4 mRNA CTD PMID:21641981 TNFSF4 Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of TNFSF4 mRNA CTD PMID:23724009 TNFSF4 Human alpha-amanitin affects expression ISO Tnfsf4 (Mus musculus) 6480464 Alpha-Amanitin affects the expression of TNFSF4 mRNA CTD PMID:38531469 TNFSF4 Human aluminium hydroxide multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 [Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFSF4 mRNA and nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFSF4 mRNA] CTD PMID:36029577 TNFSF4 Human ammonium chloride affects expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of TNFSF4 mRNA CTD PMID:16483693 TNFSF4 Human amphotericin B decreases expression EXP 6480464 Amphotericin B analog results in decreased expression of TNFSF4 mRNA CTD PMID:28534445 TNFSF4 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of TNFSF4 mRNA CTD PMID:20064835 more ... TNFSF4 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of TNFSF4 3' UTR CTD PMID:27901495 TNFSF4 Human benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of TNFSF4 mRNA CTD PMID:17690111 TNFSF4 Human benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benzo(b)fluoranthene] affects the expression of TNFSF4 mRNA CTD PMID:17690111 TNFSF4 Human bis(2-chloroethyl) sulfide increases expression ISO Tnfsf4 (Mus musculus) 6480464 Mustard Gas results in increased expression of TNFSF4 mRNA CTD PMID:19778212 TNFSF4 Human bisphenol A decreases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of TNFSF4 mRNA CTD PMID:27178563 TNFSF4 Human bisphenol A increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of TNFSF4 mRNA CTD PMID:30816183 and PMID:32528016 TNFSF4 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TNFSF4 mRNA CTD PMID:29275510 TNFSF4 Human bisphenol A affects expression ISO Tnfsf4 (Rattus norvegicus) 6480464 bisphenol A affects the expression of TNFSF4 mRNA CTD PMID:25181051 TNFSF4 Human bisphenol A multiple interactions ISO Tnfsf4 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of TNFSF4 mRNA CTD PMID:26496021 TNFSF4 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of TNFSF4 mRNA CTD PMID:32387340 TNFSF4 Human bleomycin A2 increases expression ISO Tnfsf4 (Mus musculus) 6480464 Bleomycin results in increased expression of TNFSF4 mRNA CTD PMID:36087614 TNFSF4 Human butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of TNFSF4 mRNA CTD PMID:26079696 TNFSF4 Human C60 fullerene increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of TNFSF4 mRNA CTD PMID:20471445 TNFSF4 Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of TNFSF4 mRNA CTD PMID:38382870 TNFSF4 Human caffeine increases expression EXP 6480464 Caffeine results in increased expression of TNFSF4 mRNA CTD PMID:18444173 TNFSF4 Human calcipotriol multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 [lithol rubine BCA analog results in increased susceptibility to calcipotriene] which results in increased expression of TNFSF4 mRNA and [lithol rubine BCA results in increased susceptibility to calcipotriene] which results in increased expression of TNFSF4 mRNA CTD PMID:29462589 TNFSF4 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of TNFSF4 mRNA CTD PMID:25979313 TNFSF4 Human carbon monoxide multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of TNFSF4 mRNA CTD PMID:29621558 TNFSF4 Human carbon nanotube increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Nanotubes and Carbon results in increased expression of TNFSF4 mRNA CTD PMID:24911292 TNFSF4 Human ceric oxide affects expression ISO Tnfsf4 (Rattus norvegicus) 6480464 ceric oxide affects the expression of TNFSF4 mRNA CTD PMID:29463257 TNFSF4 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to TNFSF4 gene] CTD PMID:28238834 TNFSF4 Human cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TNFSF4 mRNA CTD PMID:19320972 TNFSF4 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of TNFSF4 mRNA CTD PMID:19549813 TNFSF4 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of TNFSF4 mRNA CTD PMID:25562108 TNFSF4 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TNFSF4 mRNA CTD PMID:27989131 TNFSF4 Human dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFSF4 mRNA CTD PMID:16997883 TNFSF4 Human Dibutyl phosphate affects expression EXP 6480464 di-n-butylphosphoric acid affects the expression of TNFSF4 mRNA CTD PMID:37042841 TNFSF4 Human disodium selenite decreases expression EXP 6480464 Sodium Selenite results in decreased expression of TNFSF4 mRNA CTD PMID:18175754 TNFSF4 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFSF4 mRNA CTD PMID:27188386 TNFSF4 Human epoxiconazole increases expression ISO Tnfsf4 (Mus musculus) 6480464 epoxiconazole results in increased expression of TNFSF4 mRNA CTD PMID:35436446 TNFSF4 Human ethanol increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Ethanol results in increased expression of TNFSF4 mRNA CTD PMID:31078653 TNFSF4 Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of TNFSF4 mRNA CTD PMID:23649840 TNFSF4 Human flavonoids increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Flavonoids results in increased expression of TNFSF4 mRNA CTD PMID:18035473 TNFSF4 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of TNFSF4 mRNA CTD PMID:23649840 TNFSF4 Human fragrance increases expression EXP 6480464 Perfume results in increased expression of TNFSF4 mRNA CTD PMID:24768652 TNFSF4 Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of TNFSF4 mRNA CTD PMID:18444173 TNFSF4 Human graphite increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Graphite results in increased expression of TNFSF4 mRNA CTD PMID:29933104 TNFSF4 Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of TNFSF4 mRNA CTD PMID:18951874 TNFSF4 Human isoflurane decreases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Isoflurane results in decreased expression of TNFSF4 mRNA CTD PMID:16978161 TNFSF4 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of TNFSF4 mRNA CTD PMID:28988120 TNFSF4 Human lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of TNFSF4 mRNA CTD PMID:31059760 TNFSF4 Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of TNFSF4 mRNA CTD PMID:17400583 TNFSF4 Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of TNFSF4 mRNA CTD PMID:23649840 TNFSF4 Human mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of TNFSF4 mRNA]] and Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of TNFSF4 protein]] CTD PMID:19589242 TNFSF4 Human N,N-diethyl-m-toluamide multiple interactions ISO Tnfsf4 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of TNFSF4 gene CTD PMID:33148267 TNFSF4 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Particulate Matter results in increased expression of TNFSF4 mRNA] and Acetylcysteine inhibits the reaction [Vehicle Emissions results in increased expression of TNFSF4 mRNA] CTD PMID:20974985 TNFSF4 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of TNFSF4 mRNA CTD PMID:24768652 TNFSF4 Human niclosamide increases expression EXP 6480464 Niclosamide results in increased expression of TNFSF4 mRNA CTD PMID:36318118 TNFSF4 Human Nonylphenol multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 nonylphenol promotes the reaction [[Ovalbumin co-treated with Aluminum Hydroxide] results in increased expression of TNFSF4 mRNA] CTD PMID:36029577 TNFSF4 Human O-methyleugenol decreases expression EXP 6480464 methyleugenol results in decreased expression of TNFSF4 mRNA CTD PMID:32234424 TNFSF4 Human p-menthan-3-ol increases expression EXP 6480464 Menthol results in increased expression of TNFSF4 mRNA CTD PMID:26760959 TNFSF4 Human paraquat increases expression ISO Tnfsf4 (Mus musculus) 6480464 Paraquat results in increased expression of TNFSF4 mRNA CTD PMID:22938100 TNFSF4 Human pentobarbital decreases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Pentobarbital results in decreased expression of TNFSF4 mRNA CTD PMID:16978161 TNFSF4 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of TNFSF4 mRNA CTD PMID:36326898 TNFSF4 Human permethrin multiple interactions ISO Tnfsf4 (Rattus norvegicus) 6480464 [Permethrin co-treated with DEET] results in increased methylation of TNFSF4 gene CTD PMID:33148267 TNFSF4 Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of TNFSF4 mRNA CTD PMID:21632981 TNFSF4 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFSF4 mRNA CTD PMID:27188386 TNFSF4 Human simvastatin multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of TNFSF4 mRNA]] more ... CTD PMID:19589242 TNFSF4 Human simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of TNFSF4 mRNA and Simvastatin results in decreased expression of TNFSF4 protein CTD PMID:19589242 TNFSF4 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of TNFSF4 mRNA CTD PMID:20886546 TNFSF4 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of TNFSF4 mRNA CTD PMID:34032870 TNFSF4 Human sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of TNFSF4 mRNA CTD PMID:29319823 TNFSF4 Human sulfur dioxide multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of TNFSF4 mRNA CTD PMID:29621558 TNFSF4 Human tacrine increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Tacrine results in increased expression of TNFSF4 mRNA CTD PMID:12832660 TNFSF4 Human testosterone multiple interactions ISO Tnfsf4 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of TNFSF4 mRNA CTD PMID:26496021 TNFSF4 Human thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of TNFSF4 mRNA CTD PMID:22378314 TNFSF4 Human trichloroethene decreases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of TNFSF4 mRNA CTD PMID:33387578 TNFSF4 Human triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of TNFSF4 mRNA CTD PMID:37042841 TNFSF4 Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of TNFSF4 mRNA CTD PMID:29024780 TNFSF4 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of TNFSF4 mRNA CTD PMID:22378314 TNFSF4 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of TNFSF4 mRNA CTD PMID:28818685 TNFSF4 Human usnic acid increases expression EXP 6480464 usnic acid results in increased expression of TNFSF4 mRNA CTD PMID:32508146 TNFSF4 Human valproic acid affects expression ISO Tnfsf4 (Mus musculus) 6480464 Valproic Acid affects the expression of TNFSF4 mRNA CTD PMID:17292431 TNFSF4 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TNFSF4 mRNA CTD PMID:27188386 TNFSF4 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of TNFSF4 mRNA CTD PMID:26272509 TNFSF4 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TNFSF4 mRNA CTD PMID:25979313 TNFSF4 Human vinclozolin increases expression ISO Tnfsf4 (Rattus norvegicus) 6480464 vinclozolin results in increased expression of TNFSF4 mRNA CTD PMID:18629315 TNFSF4 Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of TNFSF4 mRNA CTD PMID:23649840 TNFSF4 Human zinc atom multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 [Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in increased expression of TNFSF4 mRNA CTD PMID:12517797 TNFSF4 Human zinc(0) multiple interactions ISO Tnfsf4 (Mus musculus) 6480464 [Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in increased expression of TNFSF4 mRNA CTD PMID:12517797
(-)-demecolcine (EXP) 1D-myo-inositol 1,4,5-trisphosphate (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-trinitrobenzenesulfonic acid (ISO) 2-palmitoylglycerol (EXP) 3-isobutyl-1-methyl-7H-xanthine (EXP) 6-propyl-2-thiouracil (ISO) 8-Br-cAMP (EXP) aflatoxin B1 (EXP) all-trans-retinoic acid (EXP) alpha-amanitin (ISO) aluminium hydroxide (ISO) ammonium chloride (ISO) amphotericin B (EXP) benzo[a]pyrene (EXP) benzo[b]fluoranthene (EXP) bis(2-chloroethyl) sulfide (ISO) bisphenol A (EXP,ISO) Bisphenol B (EXP) bleomycin A2 (ISO) butanal (EXP) C60 fullerene (ISO) cadmium dichloride (EXP) caffeine (EXP) calcipotriol (ISO) carbamazepine (EXP) carbon monoxide (ISO) carbon nanotube (ISO) ceric oxide (ISO) CGP 52608 (EXP) cobalt dichloride (EXP) copper(II) sulfate (EXP) cyclosporin A (EXP) dexamethasone (EXP) Dibutyl phosphate (EXP) disodium selenite (EXP) dorsomorphin (EXP) epoxiconazole (ISO) ethanol (ISO) ethyl methanesulfonate (EXP) flavonoids (ISO) formaldehyde (EXP) fragrance (EXP) genistein (EXP) graphite (ISO) hydrogen peroxide (EXP) isoflurane (ISO) leflunomide (EXP) lipopolysaccharide (EXP) methotrexate (EXP) methyl methanesulfonate (EXP) mevalonic acid (EXP) N,N-diethyl-m-toluamide (ISO) N-acetyl-L-cysteine (EXP) nickel atom (EXP) niclosamide (EXP) Nonylphenol (ISO) O-methyleugenol (EXP) p-menthan-3-ol (EXP) paraquat (ISO) pentobarbital (ISO) perfluorooctanoic acid (EXP) permethrin (ISO) quercetin (EXP) SB 431542 (EXP) simvastatin (EXP) sodium arsenite (EXP) sulfur dioxide (ISO) tacrine (ISO) testosterone (ISO) thapsigargin (EXP) trichloroethene (ISO) triphenyl phosphate (EXP) tris(2-butoxyethyl) phosphate (EXP) tunicamycin (EXP) urethane (EXP) usnic acid (EXP) valproic acid (EXP,ISO) vinclozolin (ISO) vincristine (EXP) zinc atom (ISO) zinc(0) (ISO)
TNFSF4 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 173,172,870 - 173,450,733 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 173,162,645 - 173,477,583 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 173,152,870 - 173,176,470 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 171,419,493 - 171,443,094 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 169,884,527 - 169,908,128 NCBI Celera 1 146,262,332 - 146,285,933 (-) NCBI Celera Cytogenetic Map 1 q25.1 NCBI HuRef 1 144,377,608 - 144,401,209 (-) NCBI HuRef CHM1_1 1 174,575,344 - 174,598,945 (-) NCBI CHM1_1 T2T-CHM13v2.0 1 172,541,831 - 172,768,144 (-) NCBI T2T-CHM13v2.0
Tnfsf4 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 1 161,223,009 - 161,245,777 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 1 161,222,980 - 161,245,981 (+) Ensembl GRCm39 Ensembl GRCm38 1 161,395,438 - 161,418,206 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 1 161,395,409 - 161,418,410 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 1 163,325,569 - 163,348,337 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 1 163,232,135 - 163,254,883 (+) NCBI MGSCv36 mm8 Celera 1 163,843,815 - 163,866,564 (+) NCBI Celera Cytogenetic Map 1 H2.1 NCBI cM Map 1 69.75 NCBI
Tnfsf4 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 13 76,256,654 - 76,280,133 (+) NCBI GRCr8 mRatBN7.2 13 73,723,329 - 73,746,809 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 13 73,723,329 - 73,746,788 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 13 76,302,498 - 76,326,020 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 13 77,600,036 - 77,623,530 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 13 74,859,914 - 74,883,412 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 13 79,269,973 - 79,293,775 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 13 79,269,973 - 79,293,778 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 13 84,166,838 - 84,190,566 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 13 77,026,337 - 77,050,223 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 13 77,040,524 - 77,064,407 (+) NCBI Celera 13 73,499,753 - 73,523,609 (+) NCBI Celera Cytogenetic Map 13 q22 NCBI
Tnfsf4 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955406 13,477,077 - 13,493,309 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955406 13,477,077 - 13,493,309 (-) NCBI ChiLan1.0 ChiLan1.0
TNFSF4 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 76,255,433 - 76,559,453 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 75,929,208 - 76,396,416 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 148,684,689 - 148,989,775 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 152,391,450 - 152,699,026 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 152,251,683 - 152,262,668 (-) Ensembl panpan1.1 panPan2 PanPan1.1 Ensembl 1 152,391,450 - 152,415,845 (-) Ensembl panpan1.1 panPan2
TNFSF4 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 7 25,883,297 - 25,909,608 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 7 25,883,251 - 25,906,892 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 7 25,415,436 - 25,441,738 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 7 25,634,585 - 25,660,879 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 7 25,634,528 - 25,660,603 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 7 25,553,133 - 25,579,437 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 7 25,626,526 - 25,652,838 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 7 25,780,205 - 25,806,523 (+) NCBI UU_Cfam_GSD_1.0
Tnfsf4 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
TNFSF4 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 9 115,550,569 - 115,659,263 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 9 115,535,185 - 115,857,457 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 9 127,042,208 - 127,049,271 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
TNFSF4 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 25 55,714,291 - 55,998,009 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 25 55,974,691 - 55,997,374 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666055 57,291,046 - 57,591,856 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Tnfsf4 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 2585 Count of miRNA genes: 743 Interacting mature miRNAs: 846 Transcripts: ENST00000281834, ENST00000367718, ENST00000488053 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
597452572 GWAS1548646_H IGA glomerulonephritis QTL GWAS1548646 (human) 0.0000005 IGA glomerulonephritis 1 173177218 173177219 Human 597437212 GWAS1533286_H systemic lupus erythematosus QTL GWAS1533286 (human) 3e-19 systemic lupus erythematosus 1 173257056 173257057 Human 597501341 GWAS1597415_H rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1597415 (human) 3e-09 rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement 1 173337507 173337508 Human 597050256 GWAS1146330_H Eczematoid dermatitis QTL GWAS1146330 (human) 4e-18 Eczematoid dermatitis 1 173194429 173194430 Human 597452566 GWAS1548640_H IGA glomerulonephritis QTL GWAS1548640 (human) 5e-08 IGA glomerulonephritis 1 173177218 173177219 Human 597467030 GWAS1563104_H rheumatoid arthritis QTL GWAS1563104 (human) 3e-09 rheumatoid arthritis 1 173330604 173330605 Human 597505303 GWAS1601377_H rheumatoid arthritis QTL GWAS1601377 (human) 2e-08 rheumatoid arthritis 1 173337507 173337508 Human 597393424 GWAS1489498_H eosinophil percentage of leukocytes QTL GWAS1489498 (human) 1e-18 eosinophil quantity (VT:0002602) blood eosinophil count to total leukocyte count ratio (CMO:0000369) 1 173262759 173262760 Human 407305687 GWAS954663_H asthma QTL GWAS954663 (human) 2e-14 asthma 1 173201479 173201480 Human 597491338 GWAS1587412_H R-warfarin measurement QTL GWAS1587412 (human) 0.000003 R-warfarin measurement 1 173305990 173305991 Human 597461642 GWAS1557716_H rheumatoid arthritis QTL GWAS1557716 (human) 1e-08 rheumatoid arthritis 1 173380586 173380587 Human 597437195 GWAS1533269_H systemic lupus erythematosus QTL GWAS1533269 (human) 6e-12 systemic lupus erythematosus 1 173377204 173377205 Human 597476229 GWAS1572303_H systemic lupus erythematosus QTL GWAS1572303 (human) 0.0000008 systemic lupus erythematosus 1 173337507 173337508 Human 597208194 GWAS1304268_H childhood onset asthma QTL GWAS1304268 (human) 2e-11 childhood onset asthma 1 173194429 173194430 Human 597279874 GWAS1375948_H rheumatoid arthritis QTL GWAS1375948 (human) 1e-10 rheumatoid arthritis 1 173197108 173197109 Human 597205635 GWAS1301709_H rheumatoid arthritis QTL GWAS1301709 (human) 2e-09 rheumatoid arthritis 1 173197108 173197109 Human 597357958 GWAS1454032_H vein graft stenosis QTL GWAS1454032 (human) 0.000009 vein graft stenosis 1 173331701 173331702 Human 597454848 GWAS1550922_H systemic lupus erythematosus QTL GWAS1550922 (human) 4e-08 systemic lupus erythematosus 1 173399532 173399533 Human 597463808 GWAS1559882_H sensory perception of sweet taste QTL GWAS1559882 (human) 0.000003 sensory perception of sweet taste 1 173406706 173406707 Human 597505920 GWAS1601994_H rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1601994 (human) 1e-11 rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement 1 173337507 173337508 Human 597366022 GWAS1462096_H chronotype measurement QTL GWAS1462096 (human) 6e-09 sleep behavior trait (VT:0001501) 1 173430538 173430539 Human 597366331 GWAS1462405_H eosinophil count QTL GWAS1462405 (human) 5e-20 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 1 173262759 173262760 Human 597457982 GWAS1554056_H eosinophil count QTL GWAS1554056 (human) 6e-13 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 1 173250332 173250333 Human 597191485 GWAS1287559_H systemic lupus erythematosus QTL GWAS1287559 (human) 2e-11 systemic lupus erythematosus 1 173197108 173197109 Human 597461946 GWAS1558020_H Eczematoid dermatitis QTL GWAS1558020 (human) 5e-09 Eczematoid dermatitis 1 173182897 173182898 Human 597437498 GWAS1533572_H systemic lupus erythematosus QTL GWAS1533572 (human) 4e-19 systemic lupus erythematosus 1 173282717 173282718 Human 597393074 GWAS1489148_H eosinophil count QTL GWAS1489148 (human) 1e-15 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 1 173262759 173262760 Human 597016871 GWAS1112945_H mosquito bite reaction itch intensity measurement QTL GWAS1112945 (human) 0.0000009 mosquito bite reaction itch intensity measurement 1 173262759 173262760 Human 597360041 GWAS1456115_H systemic lupus erythematosus QTL GWAS1456115 (human) 2e-15 systemic lupus erythematosus 1 173282717 173282718 Human 597378600 GWAS1474674_H systemic lupus erythematosus QTL GWAS1474674 (human) 0.0000001 systemic lupus erythematosus 1 173340574 173340575 Human 597372207 GWAS1468281_H chronotype measurement QTL GWAS1468281 (human) 1e-11 sleep behavior trait (VT:0001501) 1 173430538 173430539 Human 597405613 GWAS1501687_H total blood protein measurement QTL GWAS1501687 (human) 1e-08 total blood protein measurement blood protein measurement (CMO:0000028) 1 173177951 173177952 Human 407304177 GWAS953153_H asthma QTL GWAS953153 (human) 2e-16 asthma 1 173201479 173201480 Human 597378210 GWAS1474284_H systemic lupus erythematosus QTL GWAS1474284 (human) 3e-32 systemic lupus erythematosus 1 173222336 173222337 Human 596953384 GWAS1072903_H respiratory system disease QTL GWAS1072903 (human) 2e-15 respiratory system disease 1 173194429 173194430 Human 597360164 GWAS1456238_H systemic lupus erythematosus QTL GWAS1456238 (human) 2e-08 systemic lupus erythematosus 1 173282717 173282718 Human 597292376 GWAS1388450_H respiratory system disease QTL GWAS1388450 (human) 2e-15 respiratory system disease 1 173194429 173194430 Human 597355483 GWAS1451557_H systemic lupus erythematosus QTL GWAS1451557 (human) 3e-12 systemic lupus erythematosus 1 173222336 173222337 Human 597357787 GWAS1453861_H rheumatoid arthritis QTL GWAS1453861 (human) 7e-13 rheumatoid arthritis 1 173380586 173380587 Human 597354456 GWAS1450530_H multiple sclerosis QTL GWAS1450530 (human) 0.000007 multiple sclerosis 1 173315060 173315061 Human 597247194 GWAS1343268_H asthma QTL GWAS1343268 (human) 3e-08 asthma 1 173201479 173201480 Human 597379295 GWAS1475369_H diabetic retinopathy QTL GWAS1475369 (human) 0.000004 diabetic retinopathy 1 173332377 173332378 Human 597514840 GWAS1610914_H systemic scleroderma QTL GWAS1610914 (human) 6e-12 systemic scleroderma 1 173349525 173349526 Human 597357788 GWAS1453862_H rheumatoid arthritis QTL GWAS1453862 (human) 3e-11 rheumatoid arthritis 1 173380586 173380587 Human 597515349 GWAS1611423_H systemic lupus erythematosus QTL GWAS1611423 (human) 4e-28 systemic lupus erythematosus 1 173376445 173376446 Human 597477584 GWAS1573658_H systemic lupus erythematosus QTL GWAS1573658 (human) 8e-14 systemic lupus erythematosus 1 173247234 173247235 Human 596969177 GWAS1088696_H systemic lupus erythematosus QTL GWAS1088696 (human) 0.000003 systemic lupus erythematosus 1 173394963 173394964 Human 597111514 GWAS1207588_H asthma QTL GWAS1207588 (human) 5e-09 asthma 1 173194429 173194430 Human 597269844 GWAS1365918_H rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement QTL GWAS1365918 (human) 0.000007 rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement 1 173197108 173197109 Human 597475794 GWAS1571868_H systemic lupus erythematosus QTL GWAS1571868 (human) 3e-90 systemic lupus erythematosus 1 173222336 173222337 Human 597311317 GWAS1407391_H Inhalant adrenergic use measurement QTL GWAS1407391 (human) 9e-09 Inhalant adrenergic use measurement 1 173185165 173185166 Human 597475795 GWAS1571869_H systemic lupus erythematosus QTL GWAS1571869 (human) 2e-37 systemic lupus erythematosus 1 173390048 173390049 Human 597349067 GWAS1445141_H atopic eczema QTL GWAS1445141 (human) 7e-14 atopic eczema 1 173199182 173199183 Human 597620431 GWAS1677291_H tricuspid valve disease QTL GWAS1677291 (human) 2e-13 tricuspid valve disease 1 173409694 173409695 Human 597478350 GWAS1574424_H systemic lupus erythematosus QTL GWAS1574424 (human) 1e-30 systemic lupus erythematosus 1 173222336 173222337 Human 597514831 GWAS1610905_H systemic scleroderma QTL GWAS1610905 (human) 5e-12 systemic scleroderma 1 173274442 173274443 Human 596963777 GWAS1083296_H type 2 diabetes mellitus QTL GWAS1083296 (human) 0.0000005 type 2 diabetes mellitus 1 173282717 173282718 Human 597459017 GWAS1555091_H type 2 diabetes mellitus QTL GWAS1555091 (human) 0.0000005 type 2 diabetes mellitus 1 173282717 173282718 Human 597530309 GWAS1626383_H color vision disorder QTL GWAS1626383 (human) 0.0000001 color vision disorder 1 173251776 173251777 Human 597375299 GWAS1471373_H body mass index QTL GWAS1471373 (human) 2e-09 body mass index body mass index (BMI) (CMO:0000105) 1 173430538 173430539 Human 597400898 GWAS1496972_H systemic lupus erythematosus QTL GWAS1496972 (human) 7e-11 systemic lupus erythematosus 1 173338762 173338763 Human 597057229 GWAS1153303_H Eczematoid dermatitis, allergic rhinitis QTL GWAS1153303 (human) 2e-13 Eczematoid dermatitis, allergic rhinitis 1 173201479 173201480 Human 597466695 GWAS1562769_H rheumatoid arthritis QTL GWAS1562769 (human) 0.000005 rheumatoid arthritis 1 173330604 173330605 Human 597400646 GWAS1496720_H reading and spelling ability QTL GWAS1496720 (human) 0.000007 reading and spelling ability 1 173266988 173266989 Human 597356922 GWAS1452996_H systemic scleroderma, systemic lupus erythematosus QTL GWAS1452996 (human) 0.0000004 systemic scleroderma, systemic lupus erythematosus 1 173257056 173257057 Human 597399035 GWAS1495109_H systemic lupus erythematosus QTL GWAS1495109 (human) 0.000003 systemic lupus erythematosus 1 173394963 173394964 Human 597476221 GWAS1572295_H systemic lupus erythematosus QTL GWAS1572295 (human) 0.0000002 systemic lupus erythematosus 1 173222336 173222337 Human 597461886 GWAS1557960_H rheumatoid arthritis QTL GWAS1557960 (human) 1e-10 rheumatoid arthritis 1 173380586 173380587 Human 597502206 GWAS1598280_H rheumatoid arthritis QTL GWAS1598280 (human) 4e-12 rheumatoid arthritis 1 173337507 173337508 Human 597390717 GWAS1486791_H systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus QTL GWAS1486791 (human) 3e-08 systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus 1 173368608 173368609 Human 597454843 GWAS1550917_H systemic lupus erythematosus QTL GWAS1550917 (human) 1e-12 systemic lupus erythematosus 1 173222336 173222337 Human 597510010 GWAS1606084_H eosinophil count QTL GWAS1606084 (human) 4e-09 eosinophil quantity (VT:0002602) blood eosinophil count (CMO:0000033) 1 173240356 173240357 Human 597515642 GWAS1611716_H systemic lupus erythematosus QTL GWAS1611716 (human) 1e-46 systemic lupus erythematosus 1 173257056 173257057 Human 597471092 GWAS1567166_H systemic lupus erythematosus QTL GWAS1567166 (human) 0.000009 systemic lupus erythematosus 1 173209324 173209325 Human 597527413 GWAS1623487_H nephrotic syndrome QTL GWAS1623487 (human) 0.000006 nephrotic syndrome 1 173250332 173250333 Human 597469044 GWAS1565118_H systemic scleroderma QTL GWAS1565118 (human) 5e-09 systemic scleroderma 1 173363490 173363491 Human 597054207 GWAS1150281_H asthma QTL GWAS1150281 (human) 2e-09 asthma 1 173201479 173201480 Human 597438835 GWAS1534909_H systemic lupus erythematosus QTL GWAS1534909 (human) 6e-09 systemic lupus erythematosus 1 173222336 173222337 Human 597511538 GWAS1607612_H systemic lupus erythematosus, COVID-19 QTL GWAS1607612 (human) 3e-13 systemic lupus erythematosus, COVID-19 1 173359729 173359731 Human 597359592 GWAS1455666_H systemic lupus erythematosus QTL GWAS1455666 (human) 8e-09 systemic lupus erythematosus 1 173378698 173378699 Human 597359593 GWAS1455667_H systemic lupus erythematosus QTL GWAS1455667 (human) 3e-13 systemic lupus erythematosus 1 173237158 173237159 Human 597058402 GWAS1154476_H asthma, Eczematoid dermatitis, allergic rhinitis QTL GWAS1154476 (human) 1e-13 asthma, Eczematoid dermatitis, allergic rhinitis 1 173201479 173201480 Human 597533033 GWAS1629107_H body mass index QTL GWAS1629107 (human) 5e-09 body mass index body mass index (BMI) (CMO:0000105) 1 173430538 173430539 Human 597477606 GWAS1573680_H systemic lupus erythematosus QTL GWAS1573680 (human) 2e-52 systemic lupus erythematosus 1 173241650 173241651 Human 597436647 GWAS1532721_H allergic disease QTL GWAS1532721 (human) 1e-15 allergic disease 1 173177782 173177783 Human 597532390 GWAS1628464_H atopic eczema QTL GWAS1628464 (human) 2e-39 atopic eczema 1 173181588 173181589 Human 597046893 GWAS1142967_H atopic asthma QTL GWAS1142967 (human) 7e-10 atopic asthma 1 173202534 173202535 Human 597360230 GWAS1456304_H asthma QTL GWAS1456304 (human) 3e-08 asthma 1 173182897 173182898 Human 597046506 GWAS1142580_H childhood onset asthma QTL GWAS1142580 (human) 1e-11 childhood onset asthma 1 173202534 173202535 Human
RH17450
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 173,152,989 - 173,153,259 UniSTS GRCh37 Build 36 1 171,419,612 - 171,419,882 RGD NCBI36 Celera 1 146,262,451 - 146,262,721 RGD Cytogenetic Map 1 q25 UniSTS HuRef 1 144,377,727 - 144,377,997 UniSTS GeneMap99-GB4 RH Map 1 623.3 UniSTS
G42294
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 173,159,437 - 173,159,603 UniSTS GRCh37 Build 36 1 171,426,060 - 171,426,226 RGD NCBI36 Celera 1 146,268,899 - 146,269,065 RGD Cytogenetic Map 1 q25 UniSTS HuRef 1 144,384,175 - 144,384,341 UniSTS
G15923
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 173,153,801 - 173,153,925 UniSTS GRCh37 Build 36 1 171,420,424 - 171,420,548 RGD NCBI36 Celera 1 146,263,263 - 146,263,387 RGD Cytogenetic Map 1 q25 UniSTS HuRef 1 144,378,539 - 144,378,663 UniSTS
TNFSF4_270
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 173,152,833 - 173,153,732 UniSTS GRCh37 Build 36 1 171,419,456 - 171,420,355 RGD NCBI36 Celera 1 146,262,295 - 146,263,194 RGD HuRef 1 144,377,571 - 144,378,470 UniSTS
SHGC-12820
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 173,155,044 - 173,155,372 UniSTS GRCh37 Build 36 1 171,421,667 - 171,421,995 RGD NCBI36 Celera 1 146,264,506 - 146,264,834 RGD Cytogenetic Map 1 q25 UniSTS HuRef 1 144,379,782 - 144,380,110 UniSTS Stanford-G3 RH Map 1 6790.0 UniSTS Whitehead-YAC Contig Map 1 UniSTS GeneMap99-G3 RH Map 1 6746.0 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1203
2418
2787
2242
4942
1721
2339
4
621
1945
463
2267
7260
6444
52
3709
842
1730
1608
168
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000281834 ⟹ ENSP00000281834
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,183,731 - 173,207,331 (-) Ensembl
Ensembl Acc Id:
ENST00000367718 ⟹ ENSP00000356691
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,183,734 - 173,205,558 (-) Ensembl
Ensembl Acc Id:
ENST00000488053
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,188,464 - 173,205,724 (-) Ensembl
Ensembl Acc Id:
ENST00000714429 ⟹ ENSP00000519698
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,168,727 - 173,476,991 (-) Ensembl
Ensembl Acc Id:
ENST00000714430 ⟹ ENSP00000519699
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,183,797 - 173,477,036 (-) Ensembl
Ensembl Acc Id:
ENST00000714452
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,162,645 - 173,477,583 (-) Ensembl
Ensembl Acc Id:
ENST00000714453
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,172,872 - 173,190,686 (-) Ensembl
Ensembl Acc Id:
ENST00000714469
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,172,055 - 173,476,985 (-) Ensembl
Ensembl Acc Id:
ENST00000714470 ⟹ ENSP00000519727
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,183,804 - 173,476,998 (-) Ensembl
Ensembl Acc Id:
ENST00000714471 ⟹ ENSP00000519728
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 173,183,814 - 173,477,148 (-) Ensembl
RefSeq Acc Id:
NM_001297562 ⟹ NP_001284491
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,183,731 - 173,205,532 (-) NCBI CHM1_1 1 174,575,344 - 174,597,171 (-) NCBI T2T-CHM13v2.0 1 172,541,831 - 172,563,632 (-) NCBI
Sequence:
AAGGCTAACTGATTGCACAACGGCTCTGAGCAGGAGAGAGCAAAAGGTGAACCACAGTTGTACAGCTTGCTGGTGGTTGGGGTCACATTGGACTATCAATATCCAGGAGATGTTGAGAAAAAGAGGGG ATCCTTTCCAACAAGTCATCCAGCAACTCTGGGACAGAAGGAAAGCTGTGGGAAGAAAAGCAGGGTGCTGGTTTCTAGGACACTAAACCTCATGGTATCACATCGGTATCCTCGAATTCAAAGTATCA AAGTACAATTTACCGAATATAAGAAGGAGAAAGGTTTCATCCTCACTTCCCAAAAGGAGGATGAAATCATGAAGGTGCAGAACAACTCAGTCATCATCAACTGTGATGGGTTTTATCTCATCTCCCTG AAGGGCTACTTCTCCCAGGAAGTCAACATTAGCCTTCATTACCAGAAGGATGAGGAGCCCCTCTTCCAACTGAAGAAGGTCAGGTCTGTCAACTCCTTGATGGTGGCCTCTCTGACTTACAAAGACAA AGTCTACTTGAATGTGACCACTGACAATACCTCCCTGGATGACTTCCATGTGAATGGCGGAGAACTGATTCTTATCCATCAAAATCCTGGTGAATTCTGTGTCCTTTGAGGGGCTGATGGCAATATCT AAAACCAGGCACCAGCATGAACACCAAGCTGGGGGTGGACAGGGCATGGATTCTTCATTGCAAGTGAAGGAGCCTCCCAGCTCAGCCACGTGGGATGTGACAAGAAGCAGATCCTGGCCCTCCCGCCC CCACCCCTCAGGGATATTTAAAACTTATTTTATATACCAGTTAATCTTATTTATCCTTATATTTTCTAAATTGCCTAGCCGTCACACCCCAAGATTGCCTTGAGCCTACTAGGCACCTTTGTGAGAAA GAAAAAATAGATGCCTCTTCTTCAAGATGCATTGTTTCTATTGGTCAGGCAATTGTCATAATAAACTTATGTCATTGAAAACGGTACCTGACTACCATTTGCTGGAAATTTGACATGTGTGTGGCATT ATCAAAATGAAGAGGAGCAAGGAGTGAAGGAGTGGGGTTATGAATCTGCCAAAGGTGGTATGAACCAACCCCTGGAAGCCAAAGCGGCCTCTCCAAGGTTAAATTGATTGCAGTTTGCATATTGCCTA AATTTAAACTTTCTCATTTGGTGGGGGTTCAAAAGAAGAATCAGCTTGTGAAAAATCAGGACTTGAAGAGAGCCGTCTAAGAAATACCACGTGCTTTTTTTCTTTACCATTTTGCTTTCCCAGCCTCC AAACATAGTTAATAGAAATTTCCCTTCAAAGAACTGTCTGGGGATGTGATGCTTTGAAAAATCTAATCAGTGACTTAAGAGAGATTTTCTTGTATACAGGGAGAGTGAGATAACTTATTGTGAAGGGT TAGCTTTACTGTACAGGATAGCAGGGAACTGGACATCTCAGGGTAAAAGTCAGTACGGATTTTAATAGCCTGGGGAGGAAAACACATTCTTTGCCACAGACAGGCAAAGCAACACATGCTCATCCTCC TGCCTATGCTGAGATACGCACTCAGCTCCATGTCTTGTACACACAGAAACATTGCTGGTTTCAAGAAATGAGGTGATCCTATTATCAAATTCAATCTGATGTCAAATAGCACTAAGAAGTTATTGTGC CTTATGAAAAATAATGATCTCTGTCTAGAAATACCATAGACCATATATAGTCTCACATTGATAATTGAAACTAGAAGGGTCTATAATCAGCCTATGCCAGGGCTTCAATGGAATAGTATCCCCTTATG TTTAGTTGAAATGTCCCCTTAACTTGATATAATGTGTTATGCTTATGGCGCTGTGGACAATCTGATTTTTCATGTCAACTTTCCAGATGATTTGTAACTTCTCTGTGCCAAACCTTTTATAAACATAA ATTTTTGAGATATGTATTTTAAAATTGTAGCACATGTTTCCCTGACATTTTCAATAGAGGATACAACATCACAGAATCTTTCTGGATGATTCTGTGTTATCAAGGAATTGTACTGTGCTACAATTATC TCTAGAATCTCCAGAAAGGTGGAGGGCTGTTCGCCCTTACACTAAATGGTCTCAGTTGGATTTTTTTTTCCTGTTTTCTATTTCCTCTTAAGTACACCTTCAACTATATTCCCATCCCTCTATTTTAA TCTGTTATGAAGGAAGGTAAATAAAAATGCTAAATAGAAGAAATTGTAGGTAAGGTAAGAGGAATCAAGTTCTGAGTGGCTGCCAAGGCACTCACAGAATCATAATCATGGCTAAATATTTATGGAGG GCCTACTGTGGACCAGGCACTGGGCTAAATACTTACATTTACAAGAATCATTCTGAGACAGATATTCAATGATATCTGGCTTCACTACTCAGAAGATTGTGTGTGTGTTTGTGTGTGTGTGTGTGTGT GTATTTCACTTTTTGTTATTGACCATGTTCTGCAAAATTGCAGTTACTCAGTGAGTGATATCCGAAAAAGTAAACGTTTATGACTATAGGTAATATTTAAGAAAATGCATGGTTCATTTTTAAGTTTG GAATTTTTATCTATATTTCTCACAGATGTGCAGTGCACATGCAGGCCTAAGTATATGTTGTGTGTGTTGTTTGTCTTTGATGTCATGGTCCCCTCTCTTAGGTGCTCACTCGCTTTGGGTGCACCTGG CCTGCTCTTCCCATGTTGGCCTCTGCAACCACACAGGGATATTTCTGCTATGCACCAGCCTCACTCCACCTTCCTTCCATCAAAAATATGTGTGTGTGTCTCAGTCCCTGTAAGTCATGTCCTTCACA GGGAGAATTAACCCTTCGATATACATGGCAGAGTTTTGTGGGAAAAGAATTGAATGAAAAGTCAGGAGATCAGAATTTTAAATTTGACTTAGCCACTAACTAGCCATGTAACCTTGGGAAAGTCATTT CCCATTTCTGGGTCTTGCTTTTCTTTCTGTTAAATGAGAGGAATGTTAAATATCTAACAGTTTAGAATCTTATGCTTACAGTGTTATCTGTGAATGCACATATTAAATGTCTATGTTCTTGTTGCTAT GAGTCAAGGAGTGTAACCTTCTCCTTTACTATGTTGAATGTATTTTTTTCTGGACAAGCTTACATCTTCCTCAGCCATCTTTGTGAGTCCTTCAAGAGCAGTTATCAATTGTTAGTTAGATATTTTCT ATTTAGAGAATGCTTAAGGGATTCCAATCCCGATCCAAATCATAATTTGTTCTTAAGTATACTGGGCAGGTCCCCTATTTTAAGTCATAATTTTGTATTTAGTGCTTTCCTGGCTCTCAGAGAGTATT AATATTGATATTAATAATATAGTTAATAGTAATATTGCTATTTACATGGAAACAAATAAAAGATCTCAGAATTCACTA
hide sequence
RefSeq Acc Id:
NM_003326 ⟹ NP_003317
RefSeq Status:
REVIEWED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,183,731 - 173,207,331 (-) NCBI GRCh37 1 173,152,870 - 173,176,471 (-) ENTREZGENE Build 36 1 171,419,493 - 171,443,094 (-) NCBI Archive HuRef 1 144,377,608 - 144,401,209 (-) ENTREZGENE CHM1_1 1 174,575,344 - 174,598,926 (-) NCBI T2T-CHM13v2.0 1 172,541,831 - 172,565,431 (-) NCBI
Sequence:
CAATCGCCTTTTATCTCTGGCCCTGGGACCTTTGCCTATTTTCTGATTGATAGGCTTTGTTTTGTCTTTACCTCCTTCTTTCTGGGGAAAACTTCAGTTTTATCGCACGTTCCCCTTTTCCATATCTT CATCTTCCCTCTACCCAGATTGTGAAGATGGAAAGGGTCCAACCCCTGGAAGAGAATGTGGGAAATGCAGCCAGGCCAAGATTCGAGAGGAACAAGCTATTGCTGGTGGCCTCTGTAATTCAGGGACT GGGGCTGCTCCTGTGCTTCACCTACATCTGCCTGCACTTCTCTGCTCTTCAGGTATCACATCGGTATCCTCGAATTCAAAGTATCAAAGTACAATTTACCGAATATAAGAAGGAGAAAGGTTTCATCC TCACTTCCCAAAAGGAGGATGAAATCATGAAGGTGCAGAACAACTCAGTCATCATCAACTGTGATGGGTTTTATCTCATCTCCCTGAAGGGCTACTTCTCCCAGGAAGTCAACATTAGCCTTCATTAC CAGAAGGATGAGGAGCCCCTCTTCCAACTGAAGAAGGTCAGGTCTGTCAACTCCTTGATGGTGGCCTCTCTGACTTACAAAGACAAAGTCTACTTGAATGTGACCACTGACAATACCTCCCTGGATGA CTTCCATGTGAATGGCGGAGAACTGATTCTTATCCATCAAAATCCTGGTGAATTCTGTGTCCTTTGAGGGGCTGATGGCAATATCTAAAACCAGGCACCAGCATGAACACCAAGCTGGGGGTGGACAG GGCATGGATTCTTCATTGCAAGTGAAGGAGCCTCCCAGCTCAGCCACGTGGGATGTGACAAGAAGCAGATCCTGGCCCTCCCGCCCCCACCCCTCAGGGATATTTAAAACTTATTTTATATACCAGTT AATCTTATTTATCCTTATATTTTCTAAATTGCCTAGCCGTCACACCCCAAGATTGCCTTGAGCCTACTAGGCACCTTTGTGAGAAAGAAAAAATAGATGCCTCTTCTTCAAGATGCATTGTTTCTATT GGTCAGGCAATTGTCATAATAAACTTATGTCATTGAAAACGGTACCTGACTACCATTTGCTGGAAATTTGACATGTGTGTGGCATTATCAAAATGAAGAGGAGCAAGGAGTGAAGGAGTGGGGTTATG AATCTGCCAAAGGTGGTATGAACCAACCCCTGGAAGCCAAAGCGGCCTCTCCAAGGTTAAATTGATTGCAGTTTGCATATTGCCTAAATTTAAACTTTCTCATTTGGTGGGGGTTCAAAAGAAGAATC AGCTTGTGAAAAATCAGGACTTGAAGAGAGCCGTCTAAGAAATACCACGTGCTTTTTTTCTTTACCATTTTGCTTTCCCAGCCTCCAAACATAGTTAATAGAAATTTCCCTTCAAAGAACTGTCTGGG GATGTGATGCTTTGAAAAATCTAATCAGTGACTTAAGAGAGATTTTCTTGTATACAGGGAGAGTGAGATAACTTATTGTGAAGGGTTAGCTTTACTGTACAGGATAGCAGGGAACTGGACATCTCAGG GTAAAAGTCAGTACGGATTTTAATAGCCTGGGGAGGAAAACACATTCTTTGCCACAGACAGGCAAAGCAACACATGCTCATCCTCCTGCCTATGCTGAGATACGCACTCAGCTCCATGTCTTGTACAC ACAGAAACATTGCTGGTTTCAAGAAATGAGGTGATCCTATTATCAAATTCAATCTGATGTCAAATAGCACTAAGAAGTTATTGTGCCTTATGAAAAATAATGATCTCTGTCTAGAAATACCATAGACC ATATATAGTCTCACATTGATAATTGAAACTAGAAGGGTCTATAATCAGCCTATGCCAGGGCTTCAATGGAATAGTATCCCCTTATGTTTAGTTGAAATGTCCCCTTAACTTGATATAATGTGTTATGC TTATGGCGCTGTGGACAATCTGATTTTTCATGTCAACTTTCCAGATGATTTGTAACTTCTCTGTGCCAAACCTTTTATAAACATAAATTTTTGAGATATGTATTTTAAAATTGTAGCACATGTTTCCC TGACATTTTCAATAGAGGATACAACATCACAGAATCTTTCTGGATGATTCTGTGTTATCAAGGAATTGTACTGTGCTACAATTATCTCTAGAATCTCCAGAAAGGTGGAGGGCTGTTCGCCCTTACAC TAAATGGTCTCAGTTGGATTTTTTTTTCCTGTTTTCTATTTCCTCTTAAGTACACCTTCAACTATATTCCCATCCCTCTATTTTAATCTGTTATGAAGGAAGGTAAATAAAAATGCTAAATAGAAGAA ATTGTAGGTAAGGTAAGAGGAATCAAGTTCTGAGTGGCTGCCAAGGCACTCACAGAATCATAATCATGGCTAAATATTTATGGAGGGCCTACTGTGGACCAGGCACTGGGCTAAATACTTACATTTAC AAGAATCATTCTGAGACAGATATTCAATGATATCTGGCTTCACTACTCAGAAGATTGTGTGTGTGTTTGTGTGTGTGTGTGTGTGTGTATTTCACTTTTTGTTATTGACCATGTTCTGCAAAATTGCA GTTACTCAGTGAGTGATATCCGAAAAAGTAAACGTTTATGACTATAGGTAATATTTAAGAAAATGCATGGTTCATTTTTAAGTTTGGAATTTTTATCTATATTTCTCACAGATGTGCAGTGCACATGC AGGCCTAAGTATATGTTGTGTGTGTTGTTTGTCTTTGATGTCATGGTCCCCTCTCTTAGGTGCTCACTCGCTTTGGGTGCACCTGGCCTGCTCTTCCCATGTTGGCCTCTGCAACCACACAGGGATAT TTCTGCTATGCACCAGCCTCACTCCACCTTCCTTCCATCAAAAATATGTGTGTGTGTCTCAGTCCCTGTAAGTCATGTCCTTCACAGGGAGAATTAACCCTTCGATATACATGGCAGAGTTTTGTGGG AAAAGAATTGAATGAAAAGTCAGGAGATCAGAATTTTAAATTTGACTTAGCCACTAACTAGCCATGTAACCTTGGGAAAGTCATTTCCCATTTCTGGGTCTTGCTTTTCTTTCTGTTAAATGAGAGGA ATGTTAAATATCTAACAGTTTAGAATCTTATGCTTACAGTGTTATCTGTGAATGCACATATTAAATGTCTATGTTCTTGTTGCTATGAGTCAAGGAGTGTAACCTTCTCCTTTACTATGTTGAATGTA TTTTTTTCTGGACAAGCTTACATCTTCCTCAGCCATCTTTGTGAGTCCTTCAAGAGCAGTTATCAATTGTTAGTTAGATATTTTCTATTTAGAGAATGCTTAAGGGATTCCAATCCCGATCCAAATCA TAATTTGTTCTTAAGTATACTGGGCAGGTCCCCTATTTTAAGTCATAATTTTGTATTTAGTGCTTTCCTGGCTCTCAGAGAGTATTAATATTGATATTAATAATATAGTTAATAGTAATATTGCTATT TACATGGAAACAAATAAAAGATCTCAGAATTCACTA
hide sequence
RefSeq Acc Id:
XM_011509964 ⟹ XP_011508266
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,183,731 - 173,208,900 (-) NCBI
Sequence:
CAGCTTATTTCTAGTTTCCAATAGTATTTATGGCTTTTTTTTTTTTTGCTGTGACTCTTAGTCA TTTTTTGAAAATTGACGAGTAAATAGTTACTGATTTTAATACTCTTTTATGAAGAACTATTACACAAGAATTGGGCTTTACACACTGATTTTTCCTTCAGCTTTTTTCTCCACACCCTGTATGTAACA CAAGCTTTGTTCAAGGGAATAACTATGACAAATATGTTTGGATACAATTTGATTTCTAGTTTTGGCTTGGAGTCTATGATATTGTGCCTTAGTTACCTTATCTTTCAGATAAAACTTAAATTTCTCAA CACCAGTATGTTCTCCTAATGCAAGGCATAATTATTGTAGTGAAGGTATTAATTCATATTTTAATTGATTAATACTGTAGTCATAAATGTACTTTACATTTCCCACAAACTTTCTCTTTTAAGTATGC CTCATTTCCATTTTTTCTGTGAAGTGGTATAACAACTCATACTGTCAATATCCAAAATATTTCTCCCTCCTTTCTTTACATATCTGCTGGGTGCCTCATGGGGAGCTGAGAGAGACATACTTGGCCAC AAAGAGAGACAATTCCGTCTTAAACAGCTTTTCCCCAGCATCCTTATGTTGTCCAGTACAGTGCCAGGCTCATGTGATGTACTCAGTAAATATTTGCCCATTTGAACTTTACATTATAAGTAATTTTA TCATTTATTTCATTTCATTGTTTATTTTAGTGGTAAAGGGTACCTGGTGTCTATTGATAGAATACTCTTACTTTCCAAGTTCTGAGGCCAGCCACGACCTCAAAGAAAGAAATAATCTTCAAAGCTTA TTTACATCTATTCATTTGTTCATTCATGGAAAAATTATGTACGGGAAAAATGTGAAGTGGAAGGAAAGGAGACAAGGATACCCTTCTGCTTCTTTTCTGATTGTGAAGATGGAAAGGGTCCAACCCCT GGAAGAGAATGTGGGAAATGCAGCCAGGCCAAGATTCGAGAGGAACAAGCTATTGCTGGTGGCCTCTGTAATTCAGGGACTGGGGCTGCTCCTGTGCTTCACCTACATCTGCCTGCACTTCTCTGCTC TTCAGGTATCACATCGGTATCCTCGAATTCAAAGTATCAAAGTACAATTTACCGAATATAAGAAGGAGAAAGGTTTCATCCTCACTTCCCAAAAGGAGGATGAAATCATGAAGGTGCAGAACAACTCA GTCATCATCAACTGTGATGGGTTTTATCTCATCTCCCTGAAGGGCTACTTCTCCCAGGAAGTCAACATTAGCCTTCATTACCAGAAGGATGAGGAGCCCCTCTTCCAACTGAAGAAGGTCAGGTCTGT CAACTCCTTGATGGTGGCCTCTCTGACTTACAAAGACAAAGTCTACTTGAATGTGACCACTGACAATACCTCCCTGGATGACTTCCATGTGAATGGCGGAGAACTGATTCTTATCCATCAAAATCCTG GTGAATTCTGTGTCCTTTGAGGGGCTGATGGCAATATCTAAAACCAGGCACCAGCATGAACACCAAGCTGGGGGTGGACAGGGCATGGATTCTTCATTGCAAGTGAAGGAGCCTCCCAGCTCAGCCAC GTGGGATGTGACAAGAAGCAGATCCTGGCCCTCCCGCCCCCACCCCTCAGGGATATTTAAAACTTATTTTATATACCAGTTAATCTTATTTATCCTTATATTTTCTAAATTGCCTAGCCGTCACACCC CAAGATTGCCTTGAGCCTACTAGGCACCTTTGTGAGAAAGAAAAAATAGATGCCTCTTCTTCAAGATGCATTGTTTCTATTGGTCAGGCAATTGTCATAATAAACTTATGTCATTGAAAACGGTACCT GACTACCATTTGCTGGAAATTTGACATGTGTGTGGCATTATCAAAATGAAGAGGAGCAAGGAGTGAAGGAGTGGGGTTATGAATCTGCCAAAGGTGGTATGAACCAACCCCTGGAAGCCAAAGCGGCC TCTCCAAGGTTAAATTGATTGCAGTTTGCATATTGCCTAAATTTAAACTTTCTCATTTGGTGGGGGTTCAAAAGAAGAATCAGCTTGTGAAAAATCAGGACTTGAAGAGAGCCGTCTAAGAAATACCA CGTGCTTTTTTTCTTTACCATTTTGCTTTCCCAGCCTCCAAACATAGTTAATAGAAATTTCCCTTCAAAGAACTGTCTGGGGATGTGATGCTTTGAAAAATCTAATCAGTGACTTAAGAGAGATTTTC TTGTATACAGGGAGAGTGAGATAACTTATTGTGAAGGGTTAGCTTTACTGTACAGGATAGCAGGGAACTGGACATCTCAGGGTAAAAGTCAGTACGGATTTTAATAGCCTGGGGAGGAAAACACATTC TTTGCCACAGACAGGCAAAGCAACACATGCTCATCCTCCTGCCTATGCTGAGATACGCACTCAGCTCCATGTCTTGTACACACAGAAACATTGCTGGTTTCAAGAAATGAGGTGATCCTATTATCAAA TTCAATCTGATGTCAAATAGCACTAAGAAGTTATTGTGCCTTATGAAAAATAATGATCTCTGTCTAGAAATACCATAGACCATATATAGTCTCACATTGATAATTGAAACTAGAAGGGTCTATAATCA GCCTATGCCAGGGCTTCAATGGAATAGTATCCCCTTATGTTTAGTTGAAATGTCCCCTTAACTTGATATAATGTGTTATGCTTATGGCGCTGTGGACAATCTGATTTTTCATGTCAACTTTCCAGATG ATTTGTAACTTCTCTGTGCCAAACCTTTTATAAACATAAATTTTTGAGATATGTATTTTAAAATTGTAGCACATGTTTCCCTGACATTTTCAATAGAGGATACAACATCACAGAATCTTTCTGGATGA TTCTGTGTTATCAAGGAATTGTACTGTGCTACAATTATCTCTAGAATCTCCAGAAAGGTGGAGGGCTGTTCGCCCTTACACTAAATGGTCTCAGTTGGATTTTTTTTTCCTGTTTTCTATTTCCTCTT AAGTACACCTTCAACTATATTCCCATCCCTCTATTTTAATCTGTTATGAAGGAAGGTAAATAAAAATGCTAAATAGAAGAAATTGTAGGTAAGGTAAGAGGAATCAAGTTCTGAGTGGCTGCCAAGGC ACTCACAGAATCATAATCATGGCTAAATATTTATGGAGGGCCTACTGTGGACCAGGCACTGGGCTAAATACTTACATTTACAAGAATCATTCTGAGACAGATATTCAATGATATCTGGCTTCACTACT CAGAAGATTGTGTGTGTGTTTGTGTGTGTGTGTGTGTGTGTATTTCACTTTTTGTTATTGACCATGTTCTGCAAAATTGCAGTTACTCAGTGAGTGATATCCGAAAAAGTAAACGTTTATGACTATAG GTAATATTTAAGAAAATGCATGGTTCATTTTTAAGTTTGGAATTTTTATCTATATTTCTCACAGATGTGCAGTGCACATGCAGGCCTAAGTATATGTTGTGTGTGTTGTTTGTCTTTGATGTCATGGT CCCCTCTCTTAGGTGCTCACTCGCTTTGGGTGCACCTGGCCTGCTCTTCCCATGTTGGCCTCTGCAACCACACAGGGATATTTCTGCTATGCACCAGCCTCACTCCACCTTCCTTCCATCAAAAATAT GTGTGTGTGTCTCAGTCCCTGTAAGTCATGTCCTTCACAGGGAGAATTAACCCTTCGATATACATGGCAGAGTTTTGTGGGAAAAGAATTGAATGAAAAGTCAGGAGATCAGAATTTTAAATTTGACT TAGCCACTAACTAGCCATGTAACCTTGGGAAAGTCATTTCCCATTTCTGGGTCTTGCTTTTCTTTCTGTTAAATGAGAGGAATGTTAAATATCTAACAGTTTAGAATCTTATGCTTACAGTGTTATCT GTGAATGCACATATTAAATGTCTATGTTCTTGTTGCTATGAGTCAAGGAGTGTAACCTTCTCCTTTACTATGTTGAATGTATTTTTTTCTGGACAAGCTTACATCTTCCTCAGCCATCTTTGTGAGTC CTTCAAGAGCAGTTATCAATTGTTAGTTAGATATTTTCTATTTAGAGAATGCTTAAGGGATTCCAATCCCGATCCAAATCATAATTTGTTCTTAAGTATACTGGGCAGGTCCCCTATTTTAAGTCATA ATTTTGTATTTAGTGCTTTCCTGGCTCTCAGAGAGTATTAATATTGATATTAATAATATAGTTAATAGTAATATTGCTATTTACATGGAAACAAATAAAAGATCTCAGAATTCACTA
hide sequence
RefSeq Acc Id:
XM_017002228 ⟹ XP_016857717
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,183,731 - 173,207,010 (-) NCBI
Sequence:
GGGCGCTGTTTTCCCACCAGCTCATGCTGATGGCAGCTGCAACAGCTGCAAACAGTCGCTTGGAAATAATCTTATGCCAAAAGTGTTGAGTTTTTTTTCCCTCTCCCCACAGCAATCGTAAAGTGTGG TTAAACGCCCTTCTGTCTCTCCTTTCCTTCCTTCTTTTCAGCAGTGGCAGTGGTAGGGCAGAGTGGAGGTAGGGCAGAGGCACAGCTTCTAGATCTTTTTCTTTTTCTTTGCAATGCAAGATTCCTTG TATCCCTTTATAAGCTGTCACTTTGAAGCTTTGAGTCACTGATATACCTGGTCTACCCATTGTGATAGTAATGTGTTTGATCAGGCAATTAATATTAAAAGGAAATAGGAAAGAGACCAGTTCCACTT TCCCATAATATTCATATACCCTATAGACCTGCAAGGTGATTTTCTTTGTAAAGAATGCTGAAGGTATCAATATTAATAGCGGAGCAATGTGTGCGTGCATGTGTGTGTGCCTATGTGCTCACTCATTC ACCCCAATGATTTAATCAGATATTGTTTCTCACAATCTATCTCTTCCAGTCATAATTTAAAGACATCATTTCACCTTTTCCCTACCTTATTAAATACATCATGTAGTAGGAGATTATCCTTCTAGTAT TTTCCCCATATAGTTAAAATATTTCCATTTTTCTTTCACTTTATTCTTGTTCCACACTTCTCTCTTTTGCATTATTTTTTCTTATTCAGTAGTTCAGATATACAAACATTATTAGGTATTTAAGGATG TTCTTCACTGCAGAAGATGCCACTGGAGAAAAATAAATCTATACTCTCTTCGTGTTCCTTTGTTGAGCTAGTCTGATAATCTTGTTTTCTAGGTGGTTGCTTTGGGTTAGAAATGTTTCTCCCTGATA AAGTTCAGGTAATACAAACTGATTTCTGATGGTCTTGTCTGAGATTAAGCACCTCCAATGAAACCAGAATGAGATGAGCAGTCTTGGCAAATGCCTGGGCTTGTTTCTGCCTACAGGAAATAGGGTTT TCAGTGCATGGAGGCTGGTAAGAGTGTGTGTGGTTATGATCACTGTACCACAGACAGTGCTTGTGTCTCCAAATTCCAGAAGTGTAGCTAGTGTCATGCTCAGGTCTGCAGAACAGTGAGCACAACAA CACATTGATCCTCTCCTCATCACACCACACTCTTATGTCTTCTCGCAGAACTCTTTGGGTGAAATTAAAGTAGGCGACTCGGGGAGAGGGTGTGGGGGAAGAGTAAGGTGTCCATGGCAGGATGCCCA AGACATCGACCGGATGCCCAAGACATCAACCGGAATTAGGCTCTTTTGAGAAGAAAACAAAGAGAGTAACCAAATATAGAACAGCTGAGTGCATTCACCAGTCTGGGAGCCCTGAGAGTGCTTTTTCT AACAACCACAGTGTTACATATTTCCTTACACCATGGGATGATAAAACACAGGACACATGGCTCCATTCAAGGCTAACTGATTGCACAACGGCTCTGAGCAGGAGAGAGCAAAAGGTATCACATCGGTA TCCTCGAATTCAAAGTATCAAAGTACAATTTACCGAATATAAGAAGGAGAAAGGTTTCATCCTCACTTCCCAAAAGGAGGATGAAATCATGAAGGTGCAGAACAACTCAGTCATCATCAACTGTGATG GGTTTTATCTCATCTCCCTGAAGGGCTACTTCTCCCAGGAAGTCAACATTAGCCTTCATTACCAGAAGGATGAGGAGCCCCTCTTCCAACTGAAGAAGGTCAGGTCTGTCAACTCCTTGATGGTGGCC TCTCTGACTTACAAAGACAAAGTCTACTTGAATGTGACCACTGACAATACCTCCCTGGATGACTTCCATGTGAATGGCGGAGAACTGATTCTTATCCATCAAAATCCTGGTGAATTCTGTGTCCTTTG AGGGGCTGATGGCAATATCTAAAACCAGGCACCAGCATGAACACCAAGCTGGGGGTGGACAGGGCATGGATTCTTCATTGCAAGTGAAGGAGCCTCCCAGCTCAGCCACGTGGGATGTGACAAGAAGC AGATCCTGGCCCTCCCGCCCCCACCCCTCAGGGATATTTAAAACTTATTTTATATACCAGTTAATCTTATTTATCCTTATATTTTCTAAATTGCCTAGCCGTCACACCCCAAGATTGCCTTGAGCCTA CTAGGCACCTTTGTGAGAAAGAAAAAATAGATGCCTCTTCTTCAAGATGCATTGTTTCTATTGGTCAGGCAATTGTCATAATAAACTTATGTCATTGAAAACGGTACCTGACTACCATTTGCTGGAAA TTTGACATGTGTGTGGCATTATCAAAATGAAGAGGAGCAAGGAGTGAAGGAGTGGGGTTATGAATCTGCCAAAGGTGGTATGAACCAACCCCTGGAAGCCAAAGCGGCCTCTCCAAGGTTAAATTGAT TGCAGTTTGCATATTGCCTAAATTTAAACTTTCTCATTTGGTGGGGGTTCAAAAGAAGAATCAGCTTGTGAAAAATCAGGACTTGAAGAGAGCCGTCTAAGAAATACCACGTGCTTTTTTTCTTTACC ATTTTGCTTTCCCAGCCTCCAAACATAGTTAATAGAAATTTCCCTTCAAAGAACTGTCTGGGGATGTGATGCTTTGAAAAATCTAATCAGTGACTTAAGAGAGATTTTCTTGTATACAGGGAGAGTGA GATAACTTATTGTGAAGGGTTAGCTTTACTGTACAGGATAGCAGGGAACTGGACATCTCAGGGTAAAAGTCAGTACGGATTTTAATAGCCTGGGGAGGAAAACACATTCTTTGCCACAGACAGGCAAA GCAACACATGCTCATCCTCCTGCCTATGCTGAGATACGCACTCAGCTCCATGTCTTGTACACACAGAAACATTGCTGGTTTCAAGAAATGAGGTGATCCTATTATCAAATTCAATCTGATGTCAAATA GCACTAAGAAGTTATTGTGCCTTATGAAAAATAATGATCTCTGTCTAGAAATACCATAGACCATATATAGTCTCACATTGATAATTGAAACTAGAAGGGTCTATAATCAGCCTATGCCAGGGCTTCAA TGGAATAGTATCCCCTTATGTTTAGTTGAAATGTCCCCTTAACTTGATATAATGTGTTATGCTTATGGCGCTGTGGACAATCTGATTTTTCATGTCAACTTTCCAGATGATTTGTAACTTCTCTGTGC CAAACCTTTTATAAACATAAATTTTTGAGATATGTATTTTAAAATTGTAGCACATGTTTCCCTGACATTTTCAATAGAGGATACAACATCACAGAATCTTTCTGGATGATTCTGTGTTATCAAGGAAT TGTACTGTGCTACAATTATCTCTAGAATCTCCAGAAAGGTGGAGGGCTGTTCGCCCTTACACTAAATGGTCTCAGTTGGATTTTTTTTTCCTGTTTTCTATTTCCTCTTAAGTACACCTTCAACTATA TTCCCATCCCTCTATTTTAATCTGTTATGAAGGAAGGTAAATAAAAATGCTAAATAGAAGAAATTGTAGGTAAGGTAAGAGGAATCAAGTTCTGAGTGGCTGCCAAGGCACTCACAGAATCATAATCA TGGCTAAATATTTATGGAGGGCCTACTGTGGACCAGGCACTGGGCTAAATACTTACATTTACAAGAATCATTCTGAGACAGATATTCAATGATATCTGGCTTCACTACTCAGAAGATTGTGTGTGTGT TTGTGTGTGTGTGTGTGTGTGTATTTCACTTTTTGTTATTGACCATGTTCTGCAAAATTGCAGTTACTCAGTGAGTGATATCCGAAAAAGTAAACGTTTATGACTATAGGTAATATTTAAGAAAATGC ATGGTTCATTTTTAAGTTTGGAATTTTTATCTATATTTCTCACAGATGTGCAGTGCACATGCAGGCCTAAGTATATGTTGTGTGTGTTGTTTGTCTTTGATGTCATGGTCCCCTCTCTTAGGTGCTCA CTCGCTTTGGGTGCACCTGGCCTGCTCTTCCCATGTTGGCCTCTGCAACCACACAGGGATATTTCTGCTATGCACCAGCCTCACTCCACCTTCCTTCCATCAAAAATATGTGTGTGTGTCTCAGTCCC TGTAAGTCATGTCCTTCACAGGGAGAATTAACCCTTCGATATACATGGCAGAGTTTTGTGGGAAAAGAATTGAATGAAAAGTCAGGAGATCAGAATTTTAAATTTGACTTAGCCACTAACTAGCCATG TAACCTTGGGAAAGTCATTTCCCATTTCTGGGTCTTGCTTTTCTTTCTGTTAAATGAGAGGAATGTTAAATATCTAACAGTTTAGAATCTTATGCTTACAGTGTTATCTGTGAATGCACATATTAAAT GTCTATGTTCTTGTTGCTATGAGTCAAGGAGTGTAACCTTCTCCTTTACTATGTTGAATGTATTTTTTTCTGGACAAGCTTACATCTTCCTCAGCCATCTTTGTGAGTCCTTCAAGAGCAGTTATCAA TTGTTAGTTAGATATTTTCTATTTAGAGAATGCTTAAGGGATTCCAATCCCGATCCAAATCATAATTTGTTCTTAAGTATACTGGGCAGGTCCCCTATTTTAAGTCATAATTTTGTATTTAGTGCTTT CCTGGCTCTCAGAGAGTATTAATATTGATATTAATAATATAGTTAATAGTAATATTGCTATTTACATGGAAACAAATAAAAGATCTCAGAATTCACTACT
hide sequence
RefSeq Acc Id:
XM_047429896 ⟹ XP_047285852
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,183,731 - 173,450,733 (-) NCBI
RefSeq Acc Id:
XM_047429902 ⟹ XP_047285858
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,183,731 - 173,410,012 (-) NCBI
RefSeq Acc Id:
XM_047429908 ⟹ XP_047285864
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 173,172,870 - 173,207,017 (-) NCBI
RefSeq Acc Id:
XM_054338600 ⟹ XP_054194575
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 1 172,541,831 - 172,567,000 (-) NCBI
RefSeq Acc Id:
XM_054338601 ⟹ XP_054194576
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 1 172,541,831 - 172,565,110 (-) NCBI
RefSeq Acc Id:
XM_054338602 ⟹ XP_054194577
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 1 172,541,831 - 172,768,144 (-) NCBI
RefSeq Acc Id:
NP_003317 ⟸ NM_003326
- Peptide Label:
isoform 1
- UniProtKB:
Q8IV74 (UniProtKB/Swiss-Prot), Q5JZA5 (UniProtKB/Swiss-Prot), Q9HCN9 (UniProtKB/Swiss-Prot), P23510 (UniProtKB/Swiss-Prot), A0A024R937 (UniProtKB/TrEMBL), A0A0U5CJ97 (UniProtKB/TrEMBL), Q6FGS4 (UniProtKB/TrEMBL)
- Sequence:
MERVQPLEENVGNAARPRFERNKLLLVASVIQGLGLLLCFTYICLHFSALQVSHRYPRIQSIKVQFTEYKKEKGFILTSQKEDEIMKVQNNSVIINCDGFYLISLKGYFSQEVNISLHYQKDEEPLFQ LKKVRSVNSLMVASLTYKDKVYLNVTTDNTSLDDFHVNGGELILIHQNPGEFCVL
hide sequence
RefSeq Acc Id:
NP_001284491 ⟸ NM_001297562
- Peptide Label:
isoform 2
- UniProtKB:
P23510 (UniProtKB/Swiss-Prot)
- Sequence:
MVSHRYPRIQSIKVQFTEYKKEKGFILTSQKEDEIMKVQNNSVIINCDGFYLISLKGYFSQEVN ISLHYQKDEEPLFQLKKVRSVNSLMVASLTYKDKVYLNVTTDNTSLDDFHVNGGELILIHQNPGEFCVL
hide sequence
RefSeq Acc Id:
XP_011508266 ⟸ XM_011509964
- Peptide Label:
isoform X1
- Sequence:
MYSVNICPFELYIISNFIIYFISLFILVVKGTWCLLIEYSYFPSSEASHDLKERNNLQSLFTSIHLFIHGKIMYGKNVKWKERRQGYPSASFLIVKMERVQPLEENVGNAARPRFERNKLLLVASVIQ GLGLLLCFTYICLHFSALQVSHRYPRIQSIKVQFTEYKKEKGFILTSQKEDEIMKVQNNSVIINCDGFYLISLKGYFSQEVNISLHYQKDEEPLFQLKKVRSVNSLMVASLTYKDKVYLNVTTDNTSL DDFHVNGGELILIHQNPGEFCVL
hide sequence
RefSeq Acc Id:
XP_016857717 ⟸ XM_017002228
- Peptide Label:
isoform X3
- Sequence:
MPKTSTGCPRHQPELGSFEKKTKRVTKYRTAECIHQSGSPESAFSNNHSVTYFLTPWDDKTQDT WLHSRLTDCTTALSRREQKVSHRYPRIQSIKVQFTEYKKEKGFILTSQKEDEIMKVQNNSVIINCDGFYLISLKGYFSQEVNISLHYQKDEEPLFQLKKVRSVNSLMVASLTYKDKVYLNVTTDNTSL DDFHVNGGELILIHQNPGEFCVL
hide sequence
Ensembl Acc Id:
ENSP00000281834 ⟸ ENST00000281834
Ensembl Acc Id:
ENSP00000356691 ⟸ ENST00000367718
RefSeq Acc Id:
XP_047285864 ⟸ XM_047429908
- Peptide Label:
isoform X5
RefSeq Acc Id:
XP_047285852 ⟸ XM_047429896
- Peptide Label:
isoform X2
RefSeq Acc Id:
XP_047285858 ⟸ XM_047429902
- Peptide Label:
isoform X4
- UniProtKB:
Q6FGS4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054194577 ⟸ XM_054338602
- Peptide Label:
isoform X4
- UniProtKB:
Q6FGS4 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_054194575 ⟸ XM_054338600
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_054194576 ⟸ XM_054338601
- Peptide Label:
isoform X3
Ensembl Acc Id:
ENSP00000519727 ⟸ ENST00000714470
Ensembl Acc Id:
ENSP00000519728 ⟸ ENST00000714471
Ensembl Acc Id:
ENSP00000519699 ⟸ ENST00000714430
Ensembl Acc Id:
ENSP00000519698 ⟸ ENST00000714429
RGD ID: 6787043
Promoter ID: HG_KWN:6215
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, Jurkat, K562, Lymphoblastoid
Transcripts: OTTHUMT00000098113, UC001GIV.1
Position: Human Assembly Chr Position (strand) Source Build 36 1 171,441,329 - 171,441,829 (-) MPROMDB
RGD ID: 6787044
Promoter ID: HG_KWN:6216
Type: Non-CpG
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, Lymphoblastoid
Transcripts: UC001GIW.1
Position: Human Assembly Chr Position (strand) Source Build 36 1 171,442,919 - 171,443,419 (-) MPROMDB
RGD ID: 6858140
Promoter ID: EPDNEW_H2234
Type: initiation region
Name: TNFSF4_3
Description: TNF superfamily member 4
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H2235 EPDNEW_H2236
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 1 173,205,532 - 173,205,592 EPDNEW
RGD ID: 6858142
Promoter ID: EPDNEW_H2235
Type: initiation region
Name: TNFSF4_2
Description: TNF superfamily member 4
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H2234 EPDNEW_H2236
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 1 173,207,330 - 173,207,390 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2017-03-07
TNFSF4
TNF superfamily member 4
TNFSF4
tumor necrosis factor superfamily member 4
Symbol and/or name change
5135510
APPROVED
2015-11-24
TNFSF4
tumor necrosis factor superfamily member 4
TNFSF4
tumor necrosis factor (ligand) superfamily, member 4
Symbol and/or name change
5135510
APPROVED